| |
|
n |
m±SD (min-max) U/ml |
p* |
Positive cases |
Positive rate (%) |
p** |
| T |
1a |
69 |
285±116 (130-645) |
<0.0001 |
5 |
7.2 |
<0.0001 |
| |
1b |
54 |
312±172 (131-1160) |
|
5 |
9.3 |
|
| |
2a |
57 |
439±255 (139-1450) |
|
16 |
28.1 |
|
| |
2b |
19 |
441±225 (214-1065) |
|
7 |
36.8 |
|
| |
3 |
22 |
586±395 (188-1676) |
|
10 |
45.5 |
|
| |
4 |
5 |
378±149 (199-604) |
|
1 |
20.0 |
|
| N |
0 |
168 |
343±217 (130-1676) |
0.0047 |
24 |
14.3 |
0.006 |
| |
1 |
12 |
471±314 (164-1154) |
|
5 |
41.7 |
|
| |
2 |
36 |
465±261 (131-1450) |
|
11 |
30.6 |
|
| |
3 |
10 |
479±224 (222-901) |
|
4 |
40.0 |
|
| M |
0 |
210 |
359±219 (130-1676) |
0.0003 |
36 |
17.1 |
<0.0001 |
| |
1a |
6 |
591±459 (164-1450) |
|
3 |
50.0 |
|
| |
1b |
10 |
570±269 (253-1160) |
|
5 |
50.0 |
|
| Stage |
IA |
103 |
280±117 (130-751) |
<0.0001 |
7 |
6.8 |
<0.0001 |
| |
IB |
34 |
380±188 (139-913) |
|
7 |
20.6 |
|
| |
IIA |
21 |
388±265 (207-1154) |
|
5 |
23.8 |
|
| |
IIB |
12 |
633±461 (188-1676) |
|
6 |
50.0 |
|
| |
IIIA |
28 |
411±198 (131-1209) |
|
7 |
25.0 |
|
| |
IIIB |
12 |
434±217 (199-901) |
|
4 |
33.3 |
|
| |
IV |
16 |
578±338 (164-1450) |
|
8 |
50.0 |
|
* p values indicate the results of ANOVA; ** p values indicate the results of a chisquare
test. |
